Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Supernus Pharmaceuticals, Inc.
Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference
November 26, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference
November 13, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces Third Quarter 2024 Financial Results
November 04, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024
October 31, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial Results
October 21, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder
October 17, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder
October 10, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree
September 24, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
September 19, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
August 28, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
August 19, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces Second Quarter 2024 Financial Results
August 06, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
August 01, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
July 23, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
May 23, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
May 09, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces First Quarter 2024 Financial Results
May 08, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
May 01, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
April 24, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Provides Regulatory Update for SPN-830
April 08, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus to Participate in Two Upcoming Investor Conferences
March 06, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
February 28, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
February 13, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
February 05, 2024
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces Third Quarter 2023 Financial Results
November 08, 2023
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus to Participate in the Jefferies London Healthcare Conference
November 07, 2023
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
November 02, 2023
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023
October 25, 2023
From
Supernus Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
SUPN
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.